Importance of Modulating Kynurenic Acid Metabolism—Approaches for the Treatment of Dementia
Biomolecules · 2025
DOI: 10.3390/biom15010074 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Biomolecules, 2025. Verfasst von Halina Baran und 2 weiteren Autor:innen. Beteiligte Einrichtung: Karl Landsteiner Research Institute for Neurochemistry, Neuropharmacology, Neurorehabilitation and Pain Therapy, 3362 Mauer-Amstetten, Austria. Hauptthemen laut MEDLINE: Kynurenic Acid, Dementia. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 200 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FWF Austrian Science Fund, Austrian National Bank, Austrian NFB Life Science.
Themen: Demenz
Abstract (Originalsprache)
In this article, we focus on kynurenic acid metabolism in neuropsychiatric disorders and the biochemical processes involved in memory and cognitive impairment, followed by different approaches in the fight against dementia. Kynurenic acid—a biochemical part of L-tryptophan catabolism—is synthesized from L-kynurenine by kynurenine aminotransferases. Experimental pharmacological studies have shown that elevated levels of kynurenic acid in the brain are associated with impaired learning and that lowering kynurenic acid levels can improve these symptoms. The discovery of new compounds with the ability to block kynurenine aminotransferases opens new therapeutic avenues for the treatment of memory impairment and dementia. The newly developed Helix pomatia snail model of memory can be used for the assessment of novel pharmacological approaches. Dietary supplementation with natural molecular/herbal extracts, exercise, and physical activity have significant impacts on endogenous pharmacology by reducing kynurenic acid synthesis, and these factors are likely to significantly modulate steady-state biological conditions and delay the negative consequences of aging, including the onset of pathological processes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Karl Landsteiner Research Institute for Neurochemistry, Neuropharmacology, Neurorehabilitation and Pain Therapy, 3362 Mauer-Amstetten, Austria.
- Neurophysiology Unit, Department of Biomedical Sciences, University of Veterinary Medicine Vienna, 1210 Vienna, Austria.
- St. Francis Herbarium, Monastery of the Franciscan Friars Minor, 40-760 Katowice, Poland.
- Department of Neurology, Neuropsychiatric Hospital, 3362 Mauer-Amstetten, Austria.
Förderung
- FWF Austrian Science Fund
- Austrian National Bank
- Austrian NFB Life Science
- Austrian Science Research Fund BIOMED I BMH 1
- Austrian FWF
- Austrian NFB Life Science Project
- NÖ Forschung und Bildung, Austria
Zitieren
APA
Baran, H., Jan Pietryja, M., & Kepplinger, B. (2025). Importance of Modulating Kynurenic Acid Metabolism—Approaches for the Treatment of Dementia. Biomolecules. https://doi.org/10.3390/biom15010074
Vancouver
Baran H, Jan Pietryja M, Kepplinger B. Importance of Modulating Kynurenic Acid Metabolism—Approaches for the Treatment of Dementia. Biomolecules. 2025. doi:10.3390/biom15010074
BibTeX
@article{Baran2025,
author = {Baran, Halina and Jan Pietryja, Marcelin and Kepplinger, Berthold},
title = {Importance of Modulating Kynurenic Acid Metabolism—Approaches for the Treatment of Dementia},
journal = {Biomolecules},
year = {2025},
doi = {10.3390/biom15010074}
}
EUVIMED